Advertisement
The Leading Source for Pharmaceutical & Biopharmaceutical Manufacturing News
Subscribe to Pharmaceutical Processing
View Sample

FREE Daily Email Newsletter

Production of Swine Flu Vaccine is Way Behind

October 22, 2009 4:06 am | News | Comments

SWIFTWATER, Pa. (AP) — The federal government originally promised 120 million doses of swine flu vaccine by now. Only 13 million have come through. As nervous Americans clamor for the vaccine, production is running several weeks behind schedule.

TOPICS:

Swine Flu Vaccine Lagging in New Jersey

October 22, 2009 4:03 am | News | Comments

TRENTON, N.J. (AP) — Demand for swine flu vaccine is outpacing supplies in New Jersey. Fewer than 1 in 5 of the 2,353 sites planning to provide the vaccine in the Garden State have received any. The state Health Department says New Jersey has received 234,000 of the 1 million doses ordered.

Bristol-Myers Posts Higher 3Q Sales, Lower Profit

October 22, 2009 3:59 am | News | Comments

LINDA A. JOHNSON AP Business Writer TRENTON, New Jersey (AP) — Bristol-Myers Squibb Co. on Thursday reported a solid increase in third-quarter revenue, due to strong sales growth for its blockbuster blood thinner Plavix and other key medicines, and boosted its profit forecast.

TOPICS:
Advertisement

Schering-Plough Posts 17 Percent Drop in 3Q profit

October 22, 2009 3:57 am | News | Comments

LINDA A. JOHNSON AP Business Writer KENILWORTH, N.J. (AP) — Drugmaker Schering-Plough Corp. on Thursday ported lower revenue and a smaller profit in the third quarter, partly due to slightly higher spending on taxes and research.

TOPICS:

Experts: Key Drug Facts Often Left Off FDA Labels

October 21, 2009 1:16 pm | News | Comments

MATTHEW PERRONE AP Business Writer WASHINGTON (AP) — Did you know that Lunesta will help you fall

TOPICS:

CDC Advisory Committee Recommends Cervarix to Prevent Cervical Cancer in Girls and Young Women

October 21, 2009 8:39 am | News | Comments

GlaxoSmithKline announced today that the U.S. Centers for Disease Control and Prevention’s (CDC’s)

TOPICS:

Amylin 3Q Profit Narrows on Lower Costs

October 21, 2009 5:07 am | News | Comments

SAN DIEGO (AP) — Amylin Pharmaceuticals Inc. said Tuesday its third-quarter loss narrowed as lower research and development costs offset a decline in sales of the diabetes treatment Byetta. Amylin lost $26.

TOPICS:

South Korea Approves Swine Flu Vaccine

October 21, 2009 5:03 am | News | Comments

SEOUL, South Korea (AP) — South Korea has approved the country's first locally developed vaccine for swine flu. The Korea Food and Drug Administration said Wednesday that the "Green Flu-S" vaccine developed by the local pharmaceutical firm Green Cross Corp.

TOPICS:
Advertisement

Elan Posts 3Q Profit on One-Off Gain

October 21, 2009 5:00 am | News | Comments

DUBLIN (AP) — Elan Corp. PLC said Wednesday it returned to profit in the third quarter, helped by a one-off gain from the completion of a deal with Johnson & Johnson to develop drugs for Alzheimer's disease. Elan said its net profit for the third quarter ended Sept. 30 was $52.

TOPICS:

Eli Lilly Posts 3Q Profit Ahead of Forecasts

October 21, 2009 4:56 am | News | Comments

NEW YORK (AP) — Eli Lilly & Co. said Wednesday it turned a profit in the third quarter as a legal costs came off its books, and the drugmaker raised its forecasts for the year. The Indianapolis company said it earned $941.8 million, or 86 cents per share.

TOPICS:

MacuSight Receives Fast Track Designation From FDA for Perceiva inTreatment of Diabetic Macular Edema

October 21, 2009 4:53 am | News | Comments

MacuSight, a developer ofinnovative therapeutics for the treatment of severe ocular diseases

TOPICS:

Sanofi-Aventis, Wellstat, Sign Licensing Deal for Potential Diabetes Drug

October 21, 2009 4:44 am | News | Comments

NEW YORK (AP) — Sanofi-Aventis is paying privately-held Wellstat Therapeutics Corp. up to $350 million under terms of a licensing deal for a potential diabetes drug, the companies said Wednesday. Wellstat is developing PN2034 as a potential Type II diabetes treatment.

TOPICS:

Bristol-Myers Squibb Plans 113 Job Cuts in Southern Indiana

October 21, 2009 4:41 am | News | Comments

EVANSVILLE, Ind. (AP) — Bristol-Myers Squibb Co. plans to close one of its southern Indiana facilities and cut jobs at another.

Abbott Completes Visiogen Acquisition

October 21, 2009 4:34 am | News | Comments

Abbott has completed its acquisition of privately held eye care company Visiogen, expanding the company's vision care business with a next-generation accommodating intraocular lens (IOL) technology to address presbyopia for cataract patients.

TOPICS:

Dr. Mahdi B. Fawzi Joins Warner Chilcott as President, Global Research and Development

October 21, 2009 4:29 am | News | Comments

Warner Chilcott plc announced today that Dr. Mahdi Fawzi has joined the company as President, Global Research and Development. He joins Warner Chilcott from Wyeth Pharmaceuticals, where he was responsible for directing global preclinical development activities. "Dr.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading